Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy

Hypoxic-ischemic encephalopathy is a severe condition in neonates caused by oxygen deprivation at birth, leading to brain injury, significant morbidity, and high mortality rates. This condition remains a leading cause of long-term neurodevelopmental impairments, including cerebral palsy, cognitive deficits, and epilepsy. Therapeutic hypothermia has emerged as a standard intervention for neonates with moderate-to-severe hypoxic-ischemic encephalopathy, as extensive research demonstrates its neuroprotective benefits in reducing brain injury and improving survival with fewer neurological complications. However, critical questions remain regarding optimal patient selection, timing, and efficacy in specific populations, such as preterm infants and neonates in resource-limited settings. This course provides clinicians with a comprehensive understanding of the indications, preparation, administration, and complications of therapeutic hypothermia in neonates with hypoxic-ischemic encephalopathy. Participants explore the latest evidence, including controversial aspects of treatment, while developing skills to optimize neonatal care. The course highlights the importance of interprofessional collaboration, involving neonatologists, nurses, respiratory therapists, and neurologists, to ensure precise monitoring, timely interventions, and improved patient outcomes. By enhancing their knowledge of evolving treatment standards and research advances, participants can refine clinical decision-making and deliver high-quality, evidence-based neonatal care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.